Suppr超能文献

加拿大魁北克省成年人对人乳头瘤病毒疫苗和宫颈癌筛查的接受度

Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada.

作者信息

Sauvageau Chantal, Duval Bernard, Gilca Vladimir, Lavoie France, Ouakki Manale

机构信息

Quebec Regional Public health department, Health and Social Services Agency, Quebec, Canada.

出版信息

BMC Public Health. 2007 Oct 25;7:304. doi: 10.1186/1471-2458-7-304.

Abstract

BACKGROUND

The Pap test has been used for cervical cancer screening for more than four decades. A human papillomavirus (HPV) vaccine has been approved for use in Canada and is commercially available now. These two preventive interventions should be considered simultaneously. General population support is an important factor for the successful combination of these interventions. The study had two objectives: 1) To assess practices, beliefs, and attitudes regarding Pap test screening and HPV immunization; 2) To identify socio-demographic factors for Pap screening and vaccine acceptability.

METHODS

In 2006, 500 adults were invited to participate in a telephone survey in the region of Quebec City (urban and rural population, 600 000), Canada. Some neutral and standardized information on Pap test and HPV was provided before soliciting opinions.

RESULTS

471 adults (18-69 year-olds) answered the questionnaire, the mean age was 45 years, 67% were female, and 65% had college or university degree. Eighty-six percent of women had undergone at least one Pap-test in their life, 55% in the last year, and 15% from 1 to 3 years ago. Among screened women, the test had been performed in the last three years in 100% of 18-30 year-olds, but only in 67% of 60-69 year-olds (P < 0.0001). Only 15% of respondents had heard of HPV. Eighty-seven percent agreed that HPV vaccines could prevent cervical cancer, 73% that the vaccine has to be administered before the onset of sexual activity, 89% would recommend vaccination to their daughters and nieces. Among respondents < 25 years, 91% would agree to receive the vaccine if it is publicly funded, but only 72% would agree to pay $100/dose.

CONCLUSION

There is an important heterogeneity in cervical cancer screening frequency and coverage. Despite low awareness of HPV infection, the majority of respondents would recommend or are ready to receive the HPV vaccine, but the cost could prevent its acceptability.

摘要

背景

巴氏试验用于宫颈癌筛查已逾四十载。人乳头瘤病毒(HPV)疫苗已在加拿大获批使用且现已有售。这两种预防性干预措施应同时加以考虑。公众支持是这些干预措施成功结合的重要因素。该研究有两个目标:1)评估关于巴氏试验筛查和HPV免疫接种的做法、信念及态度;2)确定巴氏筛查和疫苗可接受性的社会人口学因素。

方法

2006年,邀请500名成年人参与在加拿大魁北克市地区(城乡人口共60万)进行的电话调查。在征求意见前提供了一些关于巴氏试验和HPV的中立且标准化的信息。

结果

471名成年人(年龄在18 - 69岁之间)回答了问卷,平均年龄为45岁,67%为女性,65%拥有大专或本科学历。86%的女性一生中至少接受过一次巴氏试验,55%在过去一年接受过,15%在1至3年前接受过。在接受筛查的女性中,18 - 30岁的女性100%在过去三年进行过该项检查,而60 - 69岁的女性中只有67%(P < 0.0001)。只有15%的受访者听说过人乳头瘤病毒。87%的人同意HPV疫苗可预防宫颈癌,73%的人认为该疫苗必须在开始性行为之前接种,89%的人会向其女儿和侄女推荐接种疫苗。在年龄小于25岁的受访者中,91%的人表示如果疫苗由公共资金资助,他们会同意接种,但只有72%的人会同意支付每剂100美元。

结论

宫颈癌筛查频率和覆盖范围存在重要的异质性。尽管对HPV感染的知晓率较低,但大多数受访者会推荐或愿意接种HPV疫苗,不过成本可能会影响其可接受性。

相似文献

2
Knowledge, Attitudes and Practices of Sudanese Women Regarding the Pap Smear Test and Cervical Cancer.
Asian Pac J Cancer Prev. 2016;17(2):625-30. doi: 10.7314/apjcp.2016.17.2.625.
4
The acceptability of human papillomavirus (HPV) vaccination among women with physical disabilities.
Res Dev Disabil. 2011 Sep-Oct;32(5):2020-6. doi: 10.1016/j.ridd.2011.04.006. Epub 2011 May 14.
5
Factors associated with HPV vaccination among adult women in Quebec.
Hum Vaccin Immunother. 2013 Jul;9(7):1421-4. doi: 10.4161/hv.24603. Epub 2013 Apr 9.
6
7
Human Papillomavirus vaccination acceptability among female university students in South Africa.
Asian Pac J Cancer Prev. 2013;14(8):4865-9. doi: 10.7314/apjcp.2013.14.8.4865.
8
Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
J Low Genit Tract Dis. 2012 Jan;16(1):39-44. doi: 10.1097/LGT.0b013e31822e8e25.

引用本文的文献

2
Awareness of women about cervical smear, human papilloma virus and human papilloma virus vaccine.
Turk J Obstet Gynecol. 2019 Sep;16(3):193-198. doi: 10.4274/tjod.galenos.2019.29795. Epub 2019 Oct 10.
3
Human Papillomavirus Genotyping among Different Cervical Smears in Duhok/Iraq.
Asian Pac J Cancer Prev. 2019 Jul 1;20(7):2059-2064. doi: 10.31557/APJCP.2019.20.7.2059.
5
Promoting vaccination in the province of Québec: the PromoVaQ randomized controlled trial protocol.
BMC Public Health. 2019 Feb 6;19(1):160. doi: 10.1186/s12889-019-6468-z.
6
Impact of a vaccination promotion intervention using motivational interview techniques on long-term vaccine coverage: the PromoVac strategy.
Hum Vaccin Immunother. 2019;15(3):732-739. doi: 10.1080/21645515.2018.1549451. Epub 2019 Jan 4.
9
Underutilization of cervical cancer prevention services in low and middle income countries: a review of contributing factors.
Pan Afr Med J. 2015 Jul 30;21:231. doi: 10.11604/pamj.2015.21.231.6350. eCollection 2015.

本文引用的文献

1
Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis.
J Adolesc Health. 2007 Feb;40(2):108-15. doi: 10.1016/j.jadohealth.2006.10.007. Epub 2006 Dec 6.
2
Detection of human papillomavirus in organs of upper genital tract in women with cervical cancer.
Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1601-7. doi: 10.1111/j.1525-1438.2006.00633.x.
3
Mothers' attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study.
Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1257-61. doi: 10.1158/1055-9965.EPI-06-0041.
6
Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes.
Vaccine. 2006 Apr 12;24(16):3087-94. doi: 10.1016/j.vaccine.2006.01.048. Epub 2006 Feb 9.
8
Predictors of STI vaccine acceptability among parents and their adolescent children.
J Adolesc Health. 2005 Sep;37(3):179-86. doi: 10.1016/j.jadohealth.2005.06.004.
9
Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents.
J Low Genit Tract Dis. 2004 Jul;8(3):188-94. doi: 10.1097/00128360-200407000-00005.
10
Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control.
Vaccine. 2005 Mar 18;23(17-18):2388-94. doi: 10.1016/j.vaccine.2005.01.016.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验